Head-to-head · WeighScore
CoreAge Rx vs Lttl
The verdict
CoreAge Rx takes it — 91.8/100 to 63.5/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | CoreAge Rx | Lttl |
|---|---|---|
| WeighScore | 91.8/100 | 63.5/100 |
| Grade | A− | C |
| Scorecard rank | #1 | #206 |
| Semaglutide | $99/mo | $199/mo (all doses, compounded) |
| Tirzepatide | $149/mo | $279/mo (all doses, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #1 · A−
Strengths
- Flat all-in price with no month-two step-up
- Semaglutide and tirzepatide on one account
- All 50 states, LegitScript-verified
Where it loses points
- Not the cheapest sticker price
- Compounded only
- Pharmacy partner not yet publicly named
Graded #206 · C
Strengths
- Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
- Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill
- States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
- Microdose line prices low-dose semaglutide or tirzepatide at $149/mo month-to-month for people sensitive to side effects
- A needle-free route survives on the microdose line — an orally dissolving semaglutide tablet at $179/mo month-to-month
Where it loses points
- Four partner pharmacies are named in section 11 of the Terms — RedRock Pharmacy (St. George, UT), Health Warehouse (Florence, KY), Precision Compounding Pharmacy (Bellmore, NY) and Triad Rx (Daphne, AL), each with a website, address and phone — but nowhere a buyer is looking, and the identical block appears on Taurus Meds, Remevi, Embody and Nolu — so it reads as a shared platform bench rather than a Lttl-specific supply chain
- The advertised 'Plans start at $129/mo' is the 12-month prepay rate; true month-to-month is $199 semaglutide and $279 tirzepatide
- All 14 product cards advertise the same "from $129/mo", and on tirzepatide that price is purchasable at no tier at all — its ladder bottoms at $199, and only on a twelve-month prepay. It is unbuyable on both oral tablets too ($159 and $139 floors)
- Compounded only — no brand Wegovy, Ozempic, Zepbound or Mounjaro lane at any price
- The full-dose oral semaglutide tablet is no longer on sale — its card is hidden on the pricing page and /weight-loss offers 'semaglutide and tirzepatide injectables' only, leaving the microdose tablet as the sole needle-free GLP-1 route
- No public list of states served — eligibility depends on where unnamed 'partner providers are licensed'
- Site banner promises 'Prescribed and shipped within 48 hours' while the shipping policy states 2-5 business days to process plus 3-7 to deliver
- Medications cannot be returned or refunded once they ship from the pharmacy
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.